Active Ingredient: CLEMASTINE FUMARATE
Proprietary Name: TAVIST-1
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.34MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020925
Product Number: 001
Approval Date: Aug 21, 1992
Applicant Holder Full Name: HALEON US HOLDINGS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
